THC Was Not Uniformly Anti-Inflammatory in Arthritis Cell Cultures
THC produced both pro- and anti-inflammatory findings in arthritis-related cell experiments. The direction depended on concentration, cell preparation and activating stimulus. Calling THC simply ‘anti-inflammatory’ leaves out important parts of the evidence.
What was exposed
Investigators cultured synovial fibroblasts obtained from rheumatoid-arthritis patients and examined peripheral blood mononuclear cells from healthy donors, alone and in co-culture. THC was added across a range of laboratory concentrations.
Although the cells originated from humans, the intervention occurred in vitro. No patient received THC as arthritis treatment in this study.
Different endpoints gave different answers
At higher concentrations, THC reduced selected fibroblast inflammatory outputs and inhibited proliferation. Intermediate concentrations slightly increased proliferation. In isolated blood-cell cultures, THC decreased IL-10 and increased immunoglobulin G; co-culture responses also depended on stimulation.
Calcium and uptake experiments suggested involvement of TRPA1 for particular responses. Those mechanistic findings do not make every cytokine change a consequence of the same receptor pathway.
Suppressed output is not automatically therapeutic
When a high concentration reduces both cell proliferation and an inflammatory product, altered cell viability or activity must be considered alongside a proposed therapeutic mechanism. A change in one cytokine also cannot summarize the entire inflammatory response.
The experiment did not demonstrate reduced pain, improved joint function or acceptable systemic exposure in patients. It supplies hypotheses about cellular targets and concentration-dependent responses. Applying it to treatment or causation requires evidence that the relevant exposure reaches the target tissue and improves a clinically meaningful outcome without unacceptable effects elsewhere.
Related analysis
See our analysis of the distinction between administered dose and measured exposure.
Primary research
Torsten Lowin and colleagues. Impact of Δ9-Tetrahydrocannabinol on Rheumatoid Arthritis Synovial Fibroblasts Alone and in Co-Culture with Peripheral Blood Mononuclear Cells. Biomedicines. DOI: 10.3390/biomedicines10051118.
